ApprovalTrail

Approval · Notice of Compliance 1137 · 2000

OESCLIM: Notice of Compliance 1137

Issued October 5, 2000

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
1137
Date
October 5, 2000
Company
Fournier Pharma IncSaint-Laurent, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
New strengths: 7.5mg/pad, 15mg/pad
Therapeutic class
Estrogen

Products in this notice

BrandDINStatus today
OESCLIM02242876—
OESCLIM02242877—

Medicinal ingredients